Cargando…

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates

The development of an efficacious Plasmodium falciparum malaria vaccine remains a top priority for global health. Vaccination with irradiated sporozoites is able to provide complete sterile protection through the action of CD8(+) T cells at the liver-stage of infection. However, this method is curre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longley, Rhea J., Salman, Ahmed M., Cottingham, Matthew G., Ewer, Katie, Janse, Chris J., Khan, Shahid M., Spencer, Alexandra J., Hill, Adrian V. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490344/ https://www.ncbi.nlm.nih.gov/pubmed/26139288 http://dx.doi.org/10.1038/srep11820

Ejemplares similares

Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
por: Longley, Rhea J., et al.
Publicado: (2017)

Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates
por: Bliss, Carly M, et al.
Publicado: (2014)

Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria
por: Halbroth, Benedict R., et al.
Publicado: (2020)

Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice
por: Longley, Rhea J., et al.
Publicado: (2015)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
por: Rodríguez-Galán, Ana, et al.
Publicado: (2017)

Development of an In Vitro Assay and Demonstration of Plasmodium berghei Liver-Stage Inhibition by TRAP-Specific CD8(+) T Cells
por: Longley, Rhea J., et al.
Publicado: (2015)

Malaria vaccines: identifying Plasmodium falciparum liver-stage targets
por: Longley, Rhea J., et al.
Publicado: (2015)

Enhanced Vaccine-Induced CD8(+) T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain
por: Spencer, Alexandra J., et al.
Publicado: (2014)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
por: Ewer, Katie J., et al.
Publicado: (2015)

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
por: Milicic, Anita, et al.
Publicado: (2017)

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
por: Milicic, Anita, et al.
Publicado: (2019)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
por: Alves, Eduardo, et al.
Publicado: (2014)

Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum
por: Barry, Alyssa E., et al.
Publicado: (2009)

Protection from liver-stage malaria is dependent on a fine balance between the number of infected hepatocytes and effector CD8(+) T cells
por: Spencer, Alexandra, et al.
Publicado: (2014)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites
por: Kolli, Surendra Kumar, et al.
Publicado: (2021)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8(+) T Cells Present in the Liver
por: Spencer, Alexandra J., et al.
Publicado: (2017)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
por: Bliss, Carly M., et al.
Publicado: (2018)

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2012)

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice
por: Collins, Katharine A., et al.
Publicado: (2021)

CXCR3(+) T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
por: Bowyer, Georgina, et al.
Publicado: (2018)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
por: Hodgson, Susanne H., et al.
Publicado: (2015)

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2014)

Using Serological Markers for the Surveillance of Plasmodium vivax Malaria: A Scoping Review
por: Kartal, Lejla, et al.
Publicado: (2023)

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
por: Dicks, Matthew D. J., et al.
Publicado: (2012)

Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
por: Waghela, Ishita N., et al.
Publicado: (2022)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
por: Tiono, Alfred B., et al.
Publicado: (2018)

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
por: Atcheson, Erwan, et al.
Publicado: (2018)

Cryopreservation-related loss of antigen-specific IFNγ producing CD4(+) T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy
por: Ford, Tom, et al.
Publicado: (2017)

Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection
por: Betts, Gareth, et al.
Publicado: (2012)

A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS
por: de Barra, Eoghan, et al.
Publicado: (2014)

Sequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria?
por: Franke-Fayard, Blandine, et al.
Publicado: (2010)

Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8(+) T Cell Responses
por: Halbroth, Benedict R., et al.
Publicado: (2018)

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
por: Gimenez, Alba Marina, et al.
Publicado: (2021)

T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein
por: Forbes, Emily K., et al.
Publicado: (2012)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
por: Dicks, Matthew D.J., et al.
Publicado: (2015)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
por: Dicks, Matthew D. J., et al.
Publicado: (2015)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1
por: Dutta, Sheetij, et al.
Publicado: (2013)

Assessment of Humoral Immune Responses to Blood-Stage Malaria Antigens following ChAd63-MVA Immunization, Controlled Human Malaria Infection and Natural Exposure
por: Biswas, Sumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_okrepd9ajkvj0hkbfa06asvrnd